-
Structure and regulation of the human Nek2 centrosomal kinase.
Rellos P,
Ivins FJ,
Baxter JE,
Pike A,
Nott TJ,
Parkinson DM,
Das S,
Howell S,
Fedorov O,
Shen QY,
Fry AM,
Knapp S,
Smerdon SJ.
Structural Genomics Consortium, Botnar Research Centre, University of Oxford, Oxford OX3 7LD, United Kingdom.
The dimeric Ser/Thr kinase Nek2 regulates centrosome cohesion and separation through phosphorylation of structural components of the centrosome, and aberrant regulation of Nek2 activity can lead to aneuploid defects characteristic of cancer cells. Mutational analysis of autophosphorylation sites within the kinase domain identified by mass spectrometry shows a complex pattern of positive and negative regulatory effects on kinase activity that are correlated with effects on centrosomal splitting efficiency in vivo. The 2.2-A resolution x-ray structure of the Nek2 kinase domain in complex with a pyrrole-indolinone inhibitor reveals an inhibitory helical motif within the activation loop. This helix presents a steric barrier to formation of the active enzyme and generates a surface that may be exploitable in the design of specific inhibitors that selectively target the inactive state. Comparison of this "auto-inhibitory" conformation with similar arrangements in cyclin-dependent kinase 2 and epidermal growth factor receptor kinase suggests a role for dimerization-dependent allosteric regulation that combines with autophosphorylation and protein phosphatase 1c phosphatase activity to generate the precise spatial and temporal control required for Nek2 function in centrosomal maturation.
PMID: 17197699 [PubMed - indexed for MEDLINE]
-
Cited by 7 PubMed Central articles
-
Activation segment dimerization: a mechanism for kinase autophosphorylation of non-consensus sites.
Pike AC, Rellos P, Niesen FH, Turnbull A, Oliver AW, Parker SA, Turk BE, Pearl LH, Knapp S.
EMBO J. 2008 Feb 20; 27(4):704-14. Epub 2008 Jan 31.
[EMBO J. 2008]
-
Structure of the human protein kinase MPSK1 reveals an atypical activation loop architecture.
Eswaran J, Bernad A, Ligos JM, Guinea B, Debreczeni JE, Sobott F, Parker SA, Najmanovich R, Turk BE, Knapp S.
Structure. 2008 Jan; 16(1):115-24.
[Structure. 2008]
-
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Fedorov O, Marsden B, Pogacic V, Rellos P, Müller S, Bullock AN, Schwaller J, Sundström M, Knapp S.
Proc Natl Acad Sci U S A. 2007 Dec 18; 104(51):20523-8. Epub 2007 Dec 11.
[Proc Natl Acad Sci U S A. 2007]
- » See all...
Structures reported by this article